<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31482689</article-id>
<article-id pub-id-type="pmc">6825859</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.964</article-id>
<article-id pub-id-type="publisher-id">MGG3964</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole‐exome sequencing provides insights into monogenic disease prevalence in Northwest Russia</article-title>
<alt-title alt-title-type="left-running-head">BARBITOFF et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mgg3964-cr-0001">
<name>
<surname>Barbitoff</surname>
<given-names>Yury A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3222-440X</contrib-id>
<xref ref-type="aff" rid="mgg3964-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0002">
<name>
<surname>Skitchenko</surname>
<given-names>Rostislav K.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0003">
<name>
<surname>Poleshchuk</surname>
<given-names>Olga I.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0004">
<name>
<surname>Shikov</surname>
<given-names>Anton E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7084-0177</contrib-id>
<xref ref-type="aff" rid="mgg3964-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0005">
<name>
<surname>Serebryakova</surname>
<given-names>Elena A.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0006">
<name>
<surname>Nasykhova</surname>
<given-names>Yulia A.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0007">
<name>
<surname>Polev</surname>
<given-names>Dmitrii E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9679-2791</contrib-id>
<xref ref-type="aff" rid="mgg3964-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0008">
<name>
<surname>Shuvalova</surname>
<given-names>Anna R.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0009">
<name>
<surname>Shcherbakova</surname>
<given-names>Irina V.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0010">
<name>
<surname>Fedyakov</surname>
<given-names>Mikhail A.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0011">
<name>
<surname>Glotov</surname>
<given-names>Oleg S.</given-names>
</name>
<xref ref-type="aff" rid="mgg3964-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3964-cr-0012">
<name>
<surname>Glotov</surname>
<given-names>Andrey S.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7465-4504</contrib-id>
<xref ref-type="aff" rid="mgg3964-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="mgg3964-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg3964-cr-0013">
<name>
<surname>Predeus</surname>
<given-names>Alexander V.</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2750-1599</contrib-id>
<xref ref-type="aff" rid="mgg3964-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>predeus@bioinf.me</email>
</address>
</contrib>
</contrib-group>
<aff id="mgg3964-aff-0001">
<label><sup>1</sup></label>
<institution>Bioinformatics Institute</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Genetics and Biotechnology</named-content>
<institution>St. Petersburg State University</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0003">
<label><sup>3</sup></label>
<institution>ITMO University</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0004">
<label><sup>4</sup></label>
<institution>City Hospital No. 40</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Genomic Medicine</named-content>
<institution>D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Laboratory of Biobanking and Genomic Medicine of Institute of Translation Biomedicine</named-content>
<institution>St. Petersburg State University</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0007">
<label><sup>7</sup></label>
<institution>Cerbalab LTD</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="mgg3964-aff-0008">
<label><sup>8</sup></label>
<institution>Institute of Living Systems</institution>
<institution>Immanuel Kant Baltic Federal University</institution>
<named-content content-type="city">Kaliningrad</named-content>
<country country="RU">Russia</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Alexander V. Predeus, Bioinformatics Institute, St. Petersburg, Russia.<break></break>
Email: <email>predeus@bioinf.me</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>11</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.v7.11</issue-id>
<elocation-id>e964</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-7-e964.pdf" xlink:type="simple"></self-uri>
<abstract id="mgg3964-abs-0001">
<title>Abstract</title>
<sec id="mgg3964-sec-0001">
<title>Background</title>
<p>Allele frequency data from large exome and genome aggregation projects such as the Genome Aggregation Database (gnomAD) are of ultimate importance to the interpretation of medical resequencing data. However, allele frequencies might significantly differ in poorly studied populations that are underrepresented in large‐scale projects, such as the Russian population.</p>
</sec>
<sec id="mgg3964-sec-0002">
<title>Methods</title>
<p>In this work, we leveraged our access to a large dataset of 694 exome samples to analyze genetic variation in the Northwest Russia. We compared the spectrum of genetic variants to the dbSNP build 151, and made estimates of ClinVar‐based autosomal recessive (AR) disease allele prevalence as compared to gnomAD r. 2.1.</p>
</sec>
<sec id="mgg3964-sec-0003">
<title>Results</title>
<p>An estimated 9.3% of discovered variants were not present in dbSNP. We report statistically significant overrepresentation of pathogenic variants for several Mendelian disorders, including phenylketonuria (PAH, rs5030858), Wilson's disease (<italic>ATP7B</italic>, rs76151636), factor VII deficiency (<italic>F7</italic>, rs36209567), kyphoscoliosis type of Ehlers‐Danlos syndrome (<italic>FKBP14</italic>, rs542489955), and several other recessive pathologies. We also make primary estimates of monogenic disease incidence in the population, with retinal dystrophy, cystic fibrosis, and phenylketonuria being the most frequent AR pathologies.</p>
</sec>
<sec id="mgg3964-sec-0004">
<title>Conclusion</title>
<p>Our observations demonstrate the utility of population‐specific allele frequency data to the diagnosis of monogenic disorders using high‐throughput technologies.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg3964-kwd-0001">allele frequency</kwd>
<kwd id="mgg3964-kwd-0002">Mendelian disease</kwd>
<kwd id="mgg3964-kwd-0003">Russia</kwd>
<kwd id="mgg3964-kwd-0004">whole‐exome sequencing</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Russian Foundation for Basic Research</funding-source>
<award-id>18-415-130008</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="10"></page-count>
<word-count count="5964"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>mgg3964</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>November 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.7.0 mode:remove_FC converted:03.11.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg3964-cit-1001" publication-type="journal">
<string-name>
<surname>Barbitoff</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Skitchenko</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Poleshchuk</surname>
<given-names>OI</given-names>
</string-name>, et al. <article-title>Whole‐exome sequencing provides insights into monogenic disease prevalence in Northwest Russia</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2019</year>;<volume>7</volume>:<elocation-id>e964</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.964</pub-id>
</mixed-citation>
</p>
<fn-group id="mgg3964-ntgp-0001">
<fn fn-type="equal" id="mgg3964-note-0001">
<p>Yury A. Barbitoff and Rostislav K. Skitchenko contributed equally to the work.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="mgg3964-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Rapid development of the next‐generation sequencing (NGS) technology, including the introduction of cost‐effective targeted resequencing approaches for human genomes such as whole‐exome sequencing (WES) (Ng et al., <xref ref-type="ref" rid="mgg3964-bib-0021">2009</xref>), has dramatically enhanced the applicability of NGS methods in clinical practice (Biesecker &amp; Green, <xref ref-type="ref" rid="mgg3964-bib-0009">2014</xref>). With the development of bioinformatic software for efficient and accurate data analysis, variant interpretation, i.e. classification of genetic variants by their presumed pathogenicity, has become the most challenging step on the way from raw sequence data to the definitive molecular diagnosis (Nykamp et al., <xref ref-type="ref" rid="mgg3964-bib-0022">2017</xref>; Richards et al., <xref ref-type="ref" rid="mgg3964-bib-0024">2015</xref>). Frequency of the non‐reference allele in the population is one of the most important factors that influence variant interpretation. Over the course of the previous decade, several large‐scale projects aimed at characterizing both global and regional frequencies of variant alleles. These included 1000 Genomes project (Auton et al., <xref ref-type="ref" rid="mgg3964-bib-0004">2015</xref>) and the Exome Aggregation Consortium (ExAC)/Genome Aggregation Database (gnomAD) (Karczewski et al., <xref ref-type="ref" rid="mgg3964-bib-0015">2019</xref>; Lek et al., <xref ref-type="ref" rid="mgg3964-bib-0017">2016</xref>).</p>
<p>Despite the overwhelmingly large amount of samples in the gnomAD data (125,748 for release v. 2.1), genetic variation in many regions around the globe is still poorly studied. Many countries take efforts to fill the gap by running national genome projects (e.g., two recent studies of Qatari population [Fakhro et al., <xref ref-type="ref" rid="mgg3964-bib-0013">2016</xref>; Rodriguez‐Flores et al., <xref ref-type="ref" rid="mgg3964-bib-0025">2014</xref>]). One of such initiatives, the Genomes Russia project launched in 2015, aimed at characterizing the spectrum of genetic variation in diverse ethnic groups across Russia (Oleksyk, Brukhin, &amp; O’Brien, <xref ref-type="ref" rid="mgg3964-bib-0023">2015</xref>; Zhernakova et al., <xref ref-type="ref" rid="mgg3964-bib-0034">2018</xref>). However, the project is currently far from being completed, and the amount of samples included into the first phase of the project is insufficient to make assumptions about the prevalence of monogenic disorders (Zhernakova et al., <xref ref-type="ref" rid="mgg3964-bib-0034">2018</xref>). On the other hand, a large number of individuals have been sequenced for both clinical and research purposes in smaller projects across Russia. Previously, we have used whole exome sequencing for human genetics research (e.g., Barbitoff, Bezdvornykh, et al., <xref ref-type="ref" rid="mgg3964-bib-0005">2018</xref>) and clinical practice, with the total number of exome samples analyzed reaching 694. In this work, we decided to leverage our access to this set of samples to make a first glimpse into the spectrum of genetic variation in Russia and to identify the most prevalent disease risk alleles.</p>
</sec>
<sec id="mgg3964-sec-0006" sec-type="materials-and-methods">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="mgg3964-sec-0007">
<label>2.1</label>
<title>Sequencing data and samples</title>
<p>We used a set of 694 samples sequenced with both whole‐exome sequencing kits (Agilent SureSelect V6, Illumina Nextera RapidCapture, Roche SeqCap EZ MedExome, and Illumina TruSeq Exome) and clinical exome panel (CES; Illumina TruSight One sequencing kit) (105, 15.1%). This set of samples was partially described in (Barbitoff, Bezdvornykh, et al., <xref ref-type="ref" rid="mgg3964-bib-0005">2018</xref>; Barbitoff, Polev, et al., <xref ref-type="ref" rid="mgg3964-bib-0006">2018</xref>; Barbitoff, Serebryakova, et al., <xref ref-type="ref" rid="mgg3964-bib-0007">2018</xref>). All samples were sequenced with the Illumina HiSeq 2500 and HiSeq 4000 sequencing instruments. The dataset contained individuals aggregated from different research and clinical projects (both controls and individuals with disease [major phenotypes: maturity onset diabetes of the young (MODY), type 2 diabetes (T2D), obesity, autistic spectrum disorders (ASD), connective tissue disorders (CTD), and neurofibromatosis]) most of the individuals were of Russian (~80%) ethnicity (self‐reported) and Caucasian race; with the study participants predominantly being residents of the North‐Western region of Russia.</p>
</sec>
<sec id="mgg3964-sec-0008">
<label>2.2</label>
<title>Bioinformatic analysis</title>
<p>Bioinformatic analysis of exome sequencing data was performed using a custom pipeline based on the bwa aligner (Li &amp; Durbin, <xref ref-type="ref" rid="mgg3964-bib-0018">2009</xref>), Genome Analysis Toolkit v. 3.5., and Picard tools v. 2.2.2. The pipeline was constructed according to the GATK Best Practices workflow (DePristo et al., <xref ref-type="ref" rid="mgg3964-bib-0012">2011</xref>; van der Auwera et al., <xref ref-type="ref" rid="mgg3964-bib-0029">2013</xref>). All samples were processed with identical pipeline settings and genotyped jointly using the cohort genotyping method in GATK. Variants were annotated with SnpEff/SnpSift (Cingolani et al., <xref ref-type="ref" rid="mgg3964-bib-0010">2012</xref>) using the following resources: 1000 Genomes project allele frequencies (Auton et al., <xref ref-type="ref" rid="mgg3964-bib-0004">2015</xref>), gnomAD r.2.1 allele frequencies (Karczewski et al., <xref ref-type="ref" rid="mgg3964-bib-0015">2019</xref>; Lek et al., <xref ref-type="ref" rid="mgg3964-bib-0017">2016</xref>), ESP6500 allele frequencies (Fu et al., <xref ref-type="ref" rid="mgg3964-bib-0014">2013</xref>), pathogenicity predictions from dbNSFP (Liu et al., <xref ref-type="ref" rid="mgg3964-bib-0019">2016</xref>), ClinVar database v. 2019‐01‐10.</p>
</sec>
<sec id="mgg3964-sec-0009">
<label>2.3</label>
<title>Statistical assessment of the variants</title>
<p>To analyze the spectrum of genetic variants in the dataset, we used all SNP calls from all samples. To compare the variant call qualities of known and novel variant sites, we fitted a linear regression model to predict site‐level quality score based on variant type (known/novel) and alternative allele frequency. Statistical significance of the model coefficients was assessed using the <italic>t</italic>‐statistic. To evaluate the prevalence of disease alleles, we narrowed the dataset down to a set of individuals with well‐established phenotype without severe early‐onset Mendelian pathologies (the resulting dataset comprised population controls, individuals with multifactorial obesity, MODY, T2D, ASD, and mild forms of CTD). All samples that were reported as relatives, as well as all individual that share an unusually high proportion of heterozygous calls (as reported by the QC3 package (Guo et al., <xref ref-type="ref" rid="mgg3964-bib-0101">2014</xref>) were removed to avoid inclusion of related samples that were potentially mislabeled (Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S1</xref>). We focused on known pathogenic variants reported in ClinVar, and limited the analysis to genes that are linked to Mendelian disorders with autosomal recessive inheritance pattern. To enforce the analysis of allele prevalence, we obtained a binomial <italic>p</italic>‐value of observing <italic>n</italic> alleles in the data is sampling <italic>N</italic> chromosomes from the population with true alternative allele frequency equal to gnomAD AF for either whole dataset or for the non‐Finnish European (NFE) individuals only. We manually curated all of the findings to ensure that disease allele carriers are not parts of trios of individuals carrying the disease. Expected disease incidence was calculated under the assumption of Hardy‐Weinberg equilibrium as the square of cumulative frequency of all pathogenic variants found in a certain gene.</p>
</sec>
<sec id="mgg3964-sec-0010" sec-type="data-availability">
<label>2.4</label>
<title>Data availability</title>
<p>All scripts pertinent to the analysis are available through GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/bioinf/afpaper">https://github.com/bioinf/afpaper</ext-link>. Per gene disease variant counts complemented with the corresponding disease frequency estimates can be found in Supplementary Information Table <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S1</xref>. To access the VCF file containing allele frequency information please contact the authors.</p>
</sec>
</sec>
<sec id="mgg3964-sec-0011" sec-type="results">
<label>3</label>
<title>RESULTS</title>
<sec id="mgg3964-sec-0012">
<label>3.1</label>
<title>The spectrum of identified exome variants</title>
<p>We first set out to characterize the spectrum of genetic variants found in our sample. For the complete set of 694 study participants, we identified a total of 463,100 variant sites inside targeted exome regions. Out of these, 420,187 (90.7%) had an rsID according to the latest dbSNP build 151, and the remaining 42,913 variants were not previously reported. To ensure these non‐dbSNP variants are not predominantly composed of variant calling artifacts, we compared the distribution of quality scores for known and novel variants and found no evident differences, with novel sites having even slightly higher average quality score (linear regression coefficient <italic>p</italic>‐value = 0.034, Supplementary Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S2</xref>, see Materials and Methods). We also observed no substantial differences in the total depth or mapping quality between dbSNP and non‐dbSNP variant sites, as well as only slight decrease in the variant allele frequency for heterozygous genotypes at novel sites (Supplementary Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S3</xref>). We then assessed the distribution of these variant sites across functional impact categories as classified by SnpEff (Cingolani et al., <xref ref-type="ref" rid="mgg3964-bib-0010">2012</xref>). As expected, a vast majority of variants were silent or non‐coding variants (300,117, 64.8%); 14,106 variants were classified as high‐impact variants (with the majority of sites corresponding to protein‐truncating variants), with an average of 622.5 high‐impact variants per WES sample (134 for CES; per‐sample statistics are shown on Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S4</xref>). Interestingly, a large fraction of the variants that belonged to the high‐impact group were not reported in dbSNP (5143/14106, chi‐squared p‐value with respect to the overall distribution &lt;2.2 × 10<sup>–16</sup>). This is concordant with the observation that most novel variants identified had lower alternative allele frequency (Figure <xref ref-type="fig" rid="mgg3964-fig-0001">1</xref>b, Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S5</xref>). We then went on to assess the concordance between alternative allele frequency in our sample and in the gnomAD r. 2.1 exomes. To this end, we narrowed down our dataset to sites that have mean coverage of at least 15x across gnomAD exomes, and then assessed the linear regression coefficients for the allele frequencies. We found strong correlation between AFs within gnomAD and our dataset (<italic>R</italic>
<sup>2</sup> = 0.96, Figure <xref ref-type="fig" rid="mgg3964-fig-0001">1</xref>c, Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S6</xref>). At the same time, a total of 54,679 variants have not been reported in gnomAD. Most of these non‐gnomAD variants were also missing from dbSNP build v. 151 (37,338, 68.2%), indicating that these variants constitute a specific component of the genetic structure of the population of Northwest Russia.</p>
<fig fig-type="Figure" id="mgg3964-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>The spectrum of genetic variation in exomes of Northwest Russia. (a) Distribution of the identified variant sites by functional impact on protein structure as given by SnpEff. (b) Alternative allele frequency distribution for known (dbSNP) and novel (non‐dbSNP) variants. (c) A scatterplot of alternative allele frequencies in the dataset versus gnomAD‐based frequencies; gnomAD‐only sites, multiallelic entries, and poorly covered regions are excluded. Red circle highlights sites not present in gnomAD. (d) Principal component analysis of allele frequencies for 121,171 exome variants present in Northwest Russia and all of the gnomAD populations. AFR, African; AMR, Ad Mixed American; EAS, East Asian; NFE, non‐Finnish European; NWR, Northwest Russia; SAS, South Asian. (e) Root mean square difference in allele frequencies between NWR and different gnomAD populations for the same variant sites as in (d). Error bars represent the 95% confidence interval margins for the mean</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-7-e964-g001"></graphic>
</fig>
<p>We then investigated the relationship between the Northwest Russia (NWR) population and the major populations present in gnomAD. We first examined the correlation between alternative allele frequencies in NWR and in five major ancestral groups: African (AFR), Ad Mixed American (AMR), East Asian (EAS), non‐Finnish European (NFE), and South Asian (SAS). Expectedly, we observed the highest concordance of NWR allele frequencies with the AFs derived from the NFE population (Supporting Information Figure <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S7</xref>). Principal component analysis of allele frequencies across 121,171 exome variant sites present in our dataset and in all five gnomAD populations also showed that the NWR populations falls in close proximity to the non‐Finnish Europeans (Figure <xref ref-type="fig" rid="mgg3964-fig-0001">1</xref>d). To further validate these observations, we also calculated the root‐mean‐square deviation in allele frequencies between our dataset and gnomAD populations. Concordantly with the aforementioned findings, we observed the lowest average difference for the NFE populations (Figure <xref ref-type="fig" rid="mgg3964-fig-0001">1</xref>e). These results are in good concordance with the primary data of the Genomes Russia project (Zhernakova et al., <xref ref-type="ref" rid="mgg3964-bib-0034">2018</xref>).</p>
</sec>
<sec id="mgg3964-sec-0013">
<label>3.2</label>
<title>Analysis of disease allele prevalence</title>
<p>We then moved on to the assessment of the prevalence of disease‐causing alleles in our sample. Firstly, we have further narrowed the dataset down to a set of individuals that have a well‐established phenotype without severe early‐onset disease. Such filtering resulted in a set of 372 unrelated individuals which contained 314,902 of 463,100 (68.0%) variant calls. We then focused on variants that are reported as pathogenic in ClinVar, have a relatively low (&lt;0.5%) frequency in gnomAD, and are strictly heterozygous in the curated dataset. To statistically enhance our analysis of the allele prevalence, we calculated the binomial p‐value of obtaining the observed alternative allele counts if the true population AF matched the one reported for the NFE population in gnomAD (see Materials and Methods).</p>
<p>We found several notable examples of highly prevalent known pathogenic variants for autosomal recessive disorders in our sample (summarized in Table <xref ref-type="table" rid="mgg3964-tbl-0001">1</xref>). Of highest frequency was the rs5030858 variant in the <italic>PAH</italic> gene (MIM#612349; gnomAD NFE AF = 0.0015, <italic>p</italic> = 7.9 × 10<sup>–4</sup>), a well‐established and one of the most frequent pathogenic variant for phenylketonuria (Tighe et al., <xref ref-type="ref" rid="mgg3964-bib-0028">2003</xref>). Allele carriers for this variant were observed 6 times in smaller and 11 times in larger dataset, which corresponds to an estimated allele frequency of 0.0081. The second prevalent disease allele in the dataset was the rs36209567 variant in the factor VII (<italic>F7,</italic> MIM#613878) gene (gnomAD NFE AF = 0.001, <italic>p</italic> = .001), a mutation responsible for factor VII deficiency, a disorder that is extremely rare in general population (1:500,000, according to Wulff &amp; Herrmann, <xref ref-type="ref" rid="mgg3964-bib-0031">2000</xref>). Another example of a highly prevalent disease variant in our dataset was the rs61754365 variant in the <italic>TYR</italic> gene (MIM#606933) linked to tyrosinase‐negative albinism (Takeda, Tomita, Matsunaga, Tagami, &amp; Shubahar, <xref ref-type="ref" rid="mgg3964-bib-0027">1990</xref>) (gnomAD NFE AF = 3.2 × 10<sup>–4</sup>, <italic>p</italic> = 1.1 × 10<sup>–4</sup>). Of interest is the higher incidence of a pathogenic rs76151636 variant (gnomAD NFE AF = 0.0013, <italic>p</italic> = .016) in the <italic>ATP7B</italic> gene (MIM#606882), the causal gene for Wilson's disease (WD). The H1069Q mutation corresponding to rs76151636 is reported as the most prevalent WD mutation in Europe and North America (de Bie, Muller, Wijmenga, &amp; Klomp, <xref ref-type="ref" rid="mgg3964-bib-0011">2007</xref>), which is consistent with our findings. We also observed unusually high prevalence of the rs542489955 variant in the <italic>FKBP14</italic> gene (MIM#614505; gnomAD NFE AF = 0.001, <italic>p</italic> = .0061), a frameshift mutation linked to the kyphoscoliosis type of Ehlers‐Danlos syndrome (EDS) (Baumann et al., <xref ref-type="ref" rid="mgg3964-bib-0008">2012</xref>). This variant is the most frequent EDS mutation in our dataset, which is unusual given that <italic>FKBP14</italic>‐related EDS appears to be one of the rare forms of the disease. Among the less prevalent pathogenic variants, we observed statistically significant overrepresentation of disease alleles for Charcot‐Marie‐Tooth disease type 4B3 (<italic>SBF1</italic>, MIM#603560; rs200488568, <italic>p</italic> = 1.2 × 10<sup>–4</sup>); Maple syrup urine disease (<italic>BCKDHB</italic>, MIM#248611; rs386834233, <italic>p</italic> = .003), combined oxidative phosphorylation deficiency 10 (<italic>MTO1</italic>, MIM#614667; rs201544686, <italic>p</italic> = 4.9 × 10<sup>–4</sup>) (3 observations each), and several other recessive pathologies. Notably, we identified no prevalent protein‐truncating variants missing from ClinVar (in AR disease‐related genes), suggesting that the majority of disease alleles are shared between Russian and European populations. We also analyzed the frequency of each identified prevalent disease allele in gnomAD populations other than NFE. Interestingly, we found that one of the variants, rs38683423 in <italic>BCKDHB</italic>, is also overrepresented in the Finnish population, possibly indicating either gene flow between NWR and Finnish population or region‐specific selection against the related condition.</p>
<table-wrap id="mgg3964-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Prevalent disease alleles in the Northwest Russia dataset</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Location</th>
<th align="left" colspan="1" rowspan="1" valign="top">rsID</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">gnomAD AF</th>
<th align="left" colspan="1" rowspan="1" valign="top">gnomAD NFE AF</th>
<th align="left" colspan="1" rowspan="1" valign="top">Allele count<xref ref-type="fn" rid="mgg3964-note-0002">a</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Estimated AF (lower/upper CI)<xref ref-type="fn" rid="mgg3964-note-0003">b</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>p</italic>‐value<xref ref-type="fn" rid="mgg3964-note-0002">a</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease/condition</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">12:103234271</td>
<td align="left" colspan="1" rowspan="1">rs5030858</td>
<td align="left" colspan="1" rowspan="1">
<italic>PAH</italic>
</td>
<td align="left" colspan="1" rowspan="1">7.6 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">0.0015</td>
<td align="left" colspan="1" rowspan="1">6 (11)</td>
<td align="left" colspan="1" rowspan="1">
0.0081<break></break>
(0.0037/0.0175)
</td>
<td align="left" colspan="1" rowspan="1">7.9 × 10<sup>−4</sup> (1.1 × 10<sup>−5</sup>)</td>
<td align="left" colspan="1" rowspan="1">Phenylketonuria</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13:113772982</td>
<td align="left" colspan="1" rowspan="1">rs36209567</td>
<td align="left" colspan="1" rowspan="1">
<italic>F7</italic>
</td>
<td align="left" colspan="1" rowspan="1">5.6 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">0.0010</td>
<td align="left" colspan="1" rowspan="1">5 (7)</td>
<td align="left" colspan="1" rowspan="1">
0.0067<break></break>
(0.0029/0.0157)
</td>
<td align="left" colspan="1" rowspan="1">
0.0010<break></break>
(5.7 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Factor VII deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7:30058726</td>
<td align="left" colspan="1" rowspan="1">rs542489955</td>
<td align="left" colspan="1" rowspan="1">
<italic>FKBP14</italic>
</td>
<td align="left" colspan="1" rowspan="1">5.5 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">0.0010</td>
<td align="left" colspan="1" rowspan="1">4 (8)</td>
<td align="left" colspan="1" rowspan="1">
0.0054<break></break>
(0.0021/0.0138)
</td>
<td align="left" colspan="1" rowspan="1">
0.0061<break></break>
(9.6 × 10<sup>−5</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Ehlers‐Danlos syndrome, kyphoscoliotic type, 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11:88911771</td>
<td align="left" colspan="1" rowspan="1">rs61754365</td>
<td align="left" colspan="1" rowspan="1">
<italic>TYR</italic>
</td>
<td align="left" colspan="1" rowspan="1">2.9 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3.2 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">4 (8)</td>
<td align="left" colspan="1" rowspan="1">
0.0054<break></break>
(0.0032/0.0139)
</td>
<td align="left" colspan="1" rowspan="1">1.1 × 10<sup>−4</sup> (2.4 × 10<sup>−8</sup>)</td>
<td align="left" colspan="1" rowspan="1">Tyrosinase‐negative oculocutaneous albinism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13:52518281</td>
<td align="left" colspan="1" rowspan="1">rs76151636</td>
<td align="left" colspan="1" rowspan="1">
<italic>ATP7B</italic>
</td>
<td align="left" colspan="1" rowspan="1">9.2 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">0.0013</td>
<td align="left" colspan="1" rowspan="1">4 (6)</td>
<td align="left" colspan="1" rowspan="1">
0.0053<break></break>
(0.0021/0.0138)
</td>
<td align="left" colspan="1" rowspan="1">0.0159 (0.0095)</td>
<td align="left" colspan="1" rowspan="1">WIlson's disease</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">22:50893287</td>
<td align="left" colspan="1" rowspan="1">rs200488568</td>
<td align="left" colspan="1" rowspan="1">
<italic>SBF1</italic>
</td>
<td align="left" colspan="1" rowspan="1">3.3 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">1.4 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3 (4)</td>
<td align="left" colspan="1" rowspan="1">
0.0045<break></break>
(0.0015/0.0133)
</td>
<td align="left" colspan="1" rowspan="1">1.2 × 10<sup>−4</sup> (5.0 × 10<sup>−5</sup>)</td>
<td align="left" colspan="1" rowspan="1">Charcot‐Marit‐Tooth disease, type 4B3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2:152357937</td>
<td align="left" colspan="1" rowspan="1">rs549794342</td>
<td align="left" colspan="1" rowspan="1">
<italic>NEB</italic>
</td>
<td align="left" colspan="1" rowspan="1">2.7 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">4.7 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3 (6)</td>
<td align="left" colspan="1" rowspan="1">
0.0040<break></break>
(0.0014/0.0118)
</td>
<td align="left" colspan="1" rowspan="1">
0.0050<break></break>
(5.9 × 10<sup>−5</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Nemaline myopathy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6:74191932</td>
<td align="left" colspan="1" rowspan="1">rs201544686</td>
<td align="left" colspan="1" rowspan="1">
<italic>MTO1</italic>
</td>
<td align="left" colspan="1" rowspan="1">1.7 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">2.0 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3 (5)</td>
<td align="left" colspan="1" rowspan="1">
0.0040<break></break>
(0.0014/0.0118)
</td>
<td align="left" colspan="1" rowspan="1">4.9 × 10<sup>−4</sup> (5.4 × 10<sup>−6</sup>)</td>
<td align="left" colspan="1" rowspan="1">Combined ox. phos. deficiency 10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6:80910740</td>
<td align="left" colspan="1" rowspan="1">rs386834233</td>
<td align="left" colspan="1" rowspan="1">
<italic>BCKDHB</italic>
</td>
<td align="left" colspan="1" rowspan="1">5.5 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3.9 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">3 (4)</td>
<td align="left" colspan="1" rowspan="1">
0.0040<break></break>
(0.0014/0.0118)
</td>
<td align="left" colspan="1" rowspan="1">
3.0 × 10<sup>−3</sup>
<break></break>
(2.3 × 10<sup>−3</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Maple syrup urine disease</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5:54527618</td>
<td align="left" colspan="1" rowspan="1">rs775051461</td>
<td align="left" colspan="1" rowspan="1">
<italic>CCNO</italic>
</td>
<td align="left" colspan="1" rowspan="1">9.8 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">4.7 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">2 (2)</td>
<td align="left" colspan="1" rowspan="1">
0.0030<break></break>
(8.3 × 10<sup>−4</sup>/0.0110)
</td>
<td align="left" colspan="1" rowspan="1">
4.6 × 10<sup>−4</sup>
<break></break>
(0.0015)
</td>
<td align="left" colspan="1" rowspan="1">Ciliary dyskinesia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17:8015495</td>
<td align="left" colspan="1" rowspan="1">rs121434233</td>
<td align="left" colspan="1" rowspan="1">
<italic>ALOXE3</italic>
</td>
<td align="left" colspan="1" rowspan="1">1.5 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">2.8 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">2 (5)</td>
<td align="left" colspan="1" rowspan="1">
0.0027<break></break>
(7.4 × 10<sup>−4</sup>/0.0098)
</td>
<td align="left" colspan="1" rowspan="1">
0.018<break></break>
(5.2 × 10<sup>−5</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Autosomal recessive congenital ichthyosis 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">18:21119369</td>
<td align="left" colspan="1" rowspan="1">rs543206298</td>
<td align="left" colspan="1" rowspan="1">
<italic>NPC1</italic>
</td>
<td align="left" colspan="1" rowspan="1">7.6 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">1.1 × 10<sup>−4</sup>
</td>
<td align="left" colspan="1" rowspan="1">2 (3)</td>
<td align="left" colspan="1" rowspan="1">
0.0027<break></break>
(7.4 × 10<sup>−4</sup>/0.0098)
</td>
<td align="left" colspan="1" rowspan="1">
0.0033<break></break>
(5.2 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Niemann‐Pick disease</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8:75276240</td>
<td align="left" colspan="1" rowspan="1">rs104894080</td>
<td align="left" colspan="1" rowspan="1">
<italic>GDAP1</italic>
</td>
<td align="left" colspan="1" rowspan="1">3.2 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">7 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">2 (2)</td>
<td align="left" colspan="1" rowspan="1">
0.0027<break></break>
(7.4 × 10<sup>−4</sup>/0.0097)
</td>
<td align="left" colspan="1" rowspan="1">
0.0013<break></break>
(0.0044)
</td>
<td align="left" colspan="1" rowspan="1">Polyneuropathy, Charcot‐Marie‐Tooth intermediate A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2:73677806</td>
<td align="left" colspan="1" rowspan="1">rs1307458231</td>
<td align="left" colspan="1" rowspan="1">
<italic>ALMS1</italic>
</td>
<td align="left" colspan="1" rowspan="1">2.0 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">4.4 × 10<sup>−5</sup>
</td>
<td align="left" colspan="1" rowspan="1">2 (2)</td>
<td align="left" colspan="1" rowspan="1">
0.0027<break></break>
(7.4 × 10<sup>−4</sup>/0.0097)
</td>
<td align="left" colspan="1" rowspan="1">
5.0 × 10<sup>−4</sup>
<break></break>
(1.8 × 10<sup>−3</sup>)
</td>
<td align="left" colspan="1" rowspan="1">Alstrom syndrome</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="mgg3964-note-0002">
<label>a</label>
<p>Values in brackets are derived from larger uncurated sample (see Materials and Methods). <italic>p</italic>‐values are calculated using allele frequencies in the gnomAD non‐Finnish European (NFE) population.</p>
</fn>
<fn id="mgg3964-note-0003">
<label>b</label>
<p>95% exact confidence interval margins for binomial proportions are given.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>We then went on to estimate the prevalence of monogenic disorders based on the cumulative frequencies of pathogenic variants for these diseases. To this end, we obtained per‐gene counts of all pathogenic alleles in both curated and larger uncurated dataset (Supplementary Information Table <xref ref-type="supplementary-material" rid="mgg3964-sup-0001">S1</xref>). We focused on disease with more than 3 observations of reported pathogenic alleles in the curated dataset. Results of the prevalence analysis are summarized in Table <xref ref-type="table" rid="mgg3964-tbl-0002">2</xref>. 12 genes passed our filtering criteria, with the following disorders being the most prevalent: (a) Stargardt disease (with <italic>ABCA4,</italic> MIM#601691, as the major gene, as also reported previously (Sheremet et al., <xref ref-type="ref" rid="mgg3964-bib-0026">2017</xref>), incidence at least 1:3226), (b) cystic fibrosis (<italic>CFTR</italic>, MIM#602421, with the F508del (7:117199644:ATCT&gt;A) mutation being the dominant variant), estimated incidence 1:5263, (c) phenylketonuria (<italic>PAH</italic> gene, incidence of up to 1:5556), (d) hepatic lipase deficiency (<italic>LIPC</italic>, MIM#151670, 1:10000, with one pathogenic variant rs113298164), and (e) tyrosinase‐negative oculocutaneous albinism (<italic>TYR</italic>, 1:13158). Remarkably, our estimates of cystic fibrosis, galactosemia, and phenylketonuria incidence were concordant with previous gene‐level estimates (Abramov, Kadochnikova, Yakimova, Belousova, Maerle, Sergeev, Ragimov, Donnikov, &amp; Trofimov, <xref ref-type="ref" rid="mgg3964-bib-0002">2015</xref>, Abramov, Belousova, Kadochnikova, Ragimov, &amp; Trofimov, <xref ref-type="ref" rid="mgg3964-bib-0001">2017</xref>). On the other hand, estimated incidences of factor VII deficiency and congenital afibrinogenemia were approximately 20 to 100 times higher than the reported global ones (Mannucci, Duga, &amp; Peyvandi, <xref ref-type="ref" rid="mgg3964-bib-0020">2004</xref>; Wulff et al., <xref ref-type="ref" rid="mgg3964-bib-0031">2000</xref>), though the sample size limitation did not allow us to reliably estimate the degree of this discordance.</p>
<table-wrap id="mgg3964-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Disease prevalence estimated from known pathogenic variants’ frequencies</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Disease/condition</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene(s)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Allele count<xref ref-type="fn" rid="mgg3964-note-0004">a</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Carrier frequency (lower/upper CI)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease frequency (lower/upper CI)<xref ref-type="fn" rid="mgg3964-note-0004">a</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
Known<break></break>
frequency<xref ref-type="fn" rid="mgg3964-note-0005">b</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
Comments/<break></break>
references
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Retinal dystrophy, Stargardt disease</td>
<td align="left" colspan="1" rowspan="1">
<italic>ABCA4</italic>
</td>
<td align="left" colspan="1" rowspan="1">13 (23)</td>
<td align="left" colspan="1" rowspan="1">
0.0350<break></break>
(0.0206/0.0589)
</td>
<td align="left" colspan="1" rowspan="1">
3.1 × 10<sup>−4</sup>
<break></break>
(1.1 × 10<sup>−4</sup>/8.8 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 10,000</td>
<td align="left" colspan="1" rowspan="1">
Zol’nikova, <xref ref-type="ref" rid="mgg3964-bib-0035">2016</xref>;<break></break>
Sheremet et al., <xref ref-type="ref" rid="mgg3964-bib-0026">2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cystic fibrosis</td>
<td align="left" colspan="1" rowspan="1">
<italic>CFTR</italic>
</td>
<td align="left" colspan="1" rowspan="1">11 (19)</td>
<td align="left" colspan="1" rowspan="1">
0.0296<break></break>
(0.0167/0.0522)
</td>
<td align="left" colspan="1" rowspan="1">
2.2 × 10<sup>−4</sup>
<break></break>
(6.9 × 10<sup>−5</sup>/6.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 10,000</td>
<td align="left" colspan="1" rowspan="1">Reported carrier frequency of 0.032 (Abramov et al., <xref ref-type="ref" rid="mgg3964-bib-0002">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Phenylketonuria</td>
<td align="left" colspan="1" rowspan="1">
<italic>PAH</italic>
</td>
<td align="left" colspan="1" rowspan="1">11 (18)</td>
<td align="left" colspan="1" rowspan="1">
0.0296<break></break>
(0.0167/0.0522)
</td>
<td align="left" colspan="1" rowspan="1">
2.2 × 10<sup>−4</sup>
<break></break>
(6.9 × 10<sup>−5</sup>/6.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 10,000</td>
<td align="left" colspan="1" rowspan="1">Reported carrier frequency of 0.029 (Abramov et al., <xref ref-type="ref" rid="mgg3964-bib-0002">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Afibrinogenemia, congenital</td>
<td align="left" colspan="1" rowspan="1">
<italic>FGG</italic>
</td>
<td align="left" colspan="1" rowspan="1">7 (10)</td>
<td align="left" colspan="1" rowspan="1">
0.0190<break></break>
(0.0092/0.0387)
</td>
<td align="left" colspan="1" rowspan="1">
9.0 × 10<sup>−5</sup>
<break></break>
(2.1 × 10<sup>−5</sup>/3.8 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">Reported lobal frequency of 1 in 1,000,000 (Mannucci et al., <xref ref-type="ref" rid="mgg3964-bib-0020">2004</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatic lipase deficiency</td>
<td align="left" colspan="1" rowspan="1">
<italic>LIPC</italic>
</td>
<td align="left" colspan="1" rowspan="1">6 (14)</td>
<td align="left" colspan="1" rowspan="1">
0.0162<break></break>
(0.0075/0.0359)
</td>
<td align="left" colspan="1" rowspan="1">
6.6 × 10<sup>−5</sup>
<break></break>
(1.4 × 10<sup>−5</sup>/3.1 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tyrosinase‐negative oculocutaneous albinism</td>
<td align="left" colspan="1" rowspan="1">
<italic>TYR</italic>
</td>
<td align="left" colspan="1" rowspan="1">6 (12)</td>
<td align="left" colspan="1" rowspan="1">
0.0162<break></break>
(0.0075/0.0359)
</td>
<td align="left" colspan="1" rowspan="1">
6.6 × 10<sup>−5</sup>
<break></break>
(1.4 × 10<sup>−5</sup>/3.1 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 39,000</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peeling skin syndrome</td>
<td align="left" colspan="1" rowspan="1">
<italic>TGM5</italic>
</td>
<td align="left" colspan="1" rowspan="1">5 (8)</td>
<td align="left" colspan="1" rowspan="1">
0.0135<break></break>
(0.0058/0.0311)
</td>
<td align="left" colspan="1" rowspan="1">
4.5 × 10<sup>−5</sup>
<break></break>
(8.3 × 10<sup>−6</sup>/2.5 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Factor VII deficiency</td>
<td align="left" colspan="1" rowspan="1">
<italic>F7</italic>
</td>
<td align="left" colspan="1" rowspan="1">5 (7)</td>
<td align="left" colspan="1" rowspan="1">
0.0135<break></break>
(0.0058/0.0311)
</td>
<td align="left" colspan="1" rowspan="1">
4.6 × 10<sup>−5</sup>
<break></break>
(8.3 × 10<sup>−6</sup>/2.5 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">
Reported global frequency of<break></break>
1 in 500,000 (Wulff <italic>et al.</italic>, 2000)
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wilson's disease</td>
<td align="left" colspan="1" rowspan="1">
<italic>ATP7B</italic>
</td>
<td align="left" colspan="1" rowspan="1">4 (6)</td>
<td align="left" colspan="1" rowspan="1">
0.0108<break></break>
(0.0042/0.0274)
</td>
<td align="left" colspan="1" rowspan="1">
2.9 × 10<sup>−5</sup>
<break></break>
(4.3 × 10<sup>−6</sup>/1.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 30,000.</td>
<td align="left" colspan="1" rowspan="1">Similar global incidence reported (Ala, Walker, Ashkan, Dooley, &amp; Schilsky, <xref ref-type="ref" rid="mgg3964-bib-0003">2007</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ehlers‐Danlos syndrome, kyphoscoliotic type, 2</td>
<td align="left" colspan="1" rowspan="1">
<italic>FKBP14</italic>
</td>
<td align="left" colspan="1" rowspan="1">4 (8)</td>
<td align="left" colspan="1" rowspan="1">
0.0108<break></break>
(0.0042/0.0274)
</td>
<td align="left" colspan="1" rowspan="1">
2.9 × 10<sup>−5</sup>
<break></break>
(4.3 × 10<sup>−6</sup>/1.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fructose intolerance, hereditary</td>
<td align="left" colspan="1" rowspan="1">
<italic>ALDOB</italic>
</td>
<td align="left" colspan="1" rowspan="1">4 (7)</td>
<td align="left" colspan="1" rowspan="1">
0.0108<break></break>
(0.0042/0.0274)
</td>
<td align="left" colspan="1" rowspan="1">
2.9 × 10<sup>−5</sup>
<break></break>
(4.3 × 10<sup>−6</sup>/1.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">n.a.</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Galactosemia</td>
<td align="left" colspan="1" rowspan="1">
<italic>GALT</italic>
</td>
<td align="left" colspan="1" rowspan="1">4 (5)</td>
<td align="left" colspan="1" rowspan="1">
0.0108<break></break>
(0.0042/0.0274)
</td>
<td align="left" colspan="1" rowspan="1">
2.9 × 10<sup>−5</sup>
<break></break>
(4.3 × 10<sup>−6</sup>/1.9 × 10<sup>−4</sup>)
</td>
<td align="left" colspan="1" rowspan="1">1 in 20,000</td>
<td align="left" colspan="1" rowspan="1">
Reported carrier frequency of 0.006<break></break>
(Abramov et al., <xref ref-type="ref" rid="mgg3964-bib-0002">2015</xref>)
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="mgg3964-note-0004">
<label>a</label>
<p>Values in brackets are derived from larger uncurated sample (see Materials and Methods).</p>
</fn>
<fn id="mgg3964-note-0005">
<label>b</label>
<p>Frequency data for Russian population were obtained from literature and/or clinical genetics laboratories. n.a., no data available.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
</sec>
<sec id="mgg3964-sec-0014" sec-type="discussion">
<label>4</label>
<title>DISCUSSION</title>
<p>The genetic structure of human populations is being extensively studied all around the world. Lots of ongoing large‐scale genome projects aim at characterizing the variants that persist in each country or region, e.g. Genomics England (Walter et al., <xref ref-type="ref" rid="mgg3964-bib-0030">2015</xref>). However, there still are many white spots on the genetic map of the world which will hardly be filled in the upcoming years. With the Genomes Russia project (Oleksyk et al., <xref ref-type="ref" rid="mgg3964-bib-0023">2015</xref>) being yet far from completion, Russia remains one of such white spots. To fill this gap and provide primary data on disease allele prevalence in the North‐Western region of Russia, we utilized a dataset of 694 whole‐exome and clinical exome samples sequenced for the purposes of molecular diagnostics and/or scientific projects in Saint‐Petersburg.</p>
<p>Sets of samples that contain diseased and related individuals should be treated with caution and cannot be used as a confident source of true population allele frequency. To avoid potential false discoveries, we applied a multi‐step curation strategy to identify prevalent disease alleles and make primary estimates of disease incidence. The data curation procedure included both exclusion of individuals with poor phenotypic description and/or severe early‐onset Mendelian disorders and accurate confirmation of non‐diseased phenotype at the validation stage.</p>
<p>We demonstrate that a large portion of genetic variation in Northwest Russia is specific to this particular region, with 9.3% of variant sites identified across our dataset being not reported in the latest dbSNP build 151. Notably, we observed a generally high correspondence between the allele frequencies for exome variants between Northwest Russia and the non‐Finnish European population from gnomAD (Figure <xref ref-type="fig" rid="mgg3964-fig-0001">1</xref>). This findings supports the need for a large‐scale national genetic variation database in Russia, which would support both local and global clinical genetics research. We also show that many of the previously reported pathogenic alleles that are highly prevalent in European population are also overrepresented in residents of Northwest Russia (Table <xref ref-type="table" rid="mgg3964-tbl-0001">1</xref>), with the allele frequencies for many these alleles in Russia being substantially higher than in non‐Finnish Europeans. These include a dominant Wilson's disease allele (rs76151636, de Bie et al., <xref ref-type="ref" rid="mgg3964-bib-0011">2007</xref>), and the common phenylketonuria R408W (rs5030858) mutation in the <italic>PAH</italic> gene (Tighe et al., <xref ref-type="ref" rid="mgg3964-bib-0028">2003</xref>). Moreover, we identified no highly prevalent pathogenic or likely pathogenic variants missing from ClinVar or dbSNP in the AR disease‐related genes, indicating that, at least for recessive pathologies, much of the genetic determinants are shared between Russia and other populations.</p>
<p>Our dataset allowed us to make the first exome‐level estimates of prevalence of monogenic disorders in the region (Table <xref ref-type="table" rid="mgg3964-tbl-0002">2</xref>). Despite the low precision of the estimates due to the limited sample size, our data on two of the most common pathologies, cystic fibrosis and phenylketonuria, are concordant with previous gene‐level estimates. On the other hand, we highlight many pathologies which are at relatively high risk in Russia, including Wilson's disease, factor VII deficiency, Stargardt disease, tyrosinase‐negative oculocutaneous albinism, and several other diseases. Our results are also concordant with previous large‐scale analyses of disease allele carrier frequency for cystic fibrosis for individuals of Caucasian race (Lazarin et al., <xref ref-type="ref" rid="mgg3964-bib-0016">2013</xref>). Moreover, estimated incidence of phenylketonuria in Russia is also similar to the one reported in diverse human populations, including a recent study in China (Zhao et al., <xref ref-type="ref" rid="mgg3964-bib-0032">2019</xref>).</p>
<p>Overall, our results demonstrate the urgent need for population‐specific genetic databases for variant interpretation purposes and identification of disease risk factors in poorly studied populations. Larger sample sizes are certainly required to make confident assumptions about the prevalence of monogenic disorders and population frequencies of disease alleles. Nevertheless, we are hopeful that the data presented would assist medical genetics studies and clinical genetic analyses both inside and outside Russia.</p>
</sec>
<sec id="mgg3964-sec-0015" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>The authors declare no conflict of interest.</p>
</sec>
<sec id="mgg3964-sec-0016">
<title>ETHICAL COMPLIANCE</title>
<p>All individual studies unified here were approved by the ethical committee of the Biobank research center, and all participants provided written informed consent.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="mgg3964-sup-0001">
<caption>
<p> </p>
</caption>
<media xlink:href="MGG3-7-e964-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="mgg3964-sec-0017">
<title>ACKNOWLEDGMENTS</title>
<p>This work was support by the alpha‐Endo program (the CAF Foundation), RFBR grant 18‐415‐130008, and D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproductology, project 558‐2019‐0012 of FSBSI. Equipment of the Resource Center «Biobank» and SPBU Computational Centre was used for data analysis in this study.</p>
</ack>
<ref-list content-type="cited-references" id="mgg3964-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg3964-bib-0001">
<mixed-citation id="mgg3964-cit-0001" publication-type="journal">
<string-name>
<surname>Abramov</surname>, <given-names>D. D.</given-names>
</string-name>, <string-name>
<surname>Belousova</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Kadochnikova</surname>, <given-names>V. V.</given-names>
</string-name>, <string-name>
<surname>Ragimov</surname>, <given-names>A. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Trofimov</surname>, <given-names>D. Y.</given-names>
</string-name> (<year>2017</year>). <article-title>Carrier frequency of GJB2 and GALT mutations associated with sensorineural hearing loss and galactosemia in the Russian population</article-title>. <source xml:lang="en"/>Bulletin of Russian State Medical University, <volume>6</volume>, <fpage>20</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.24075/brsmu.2016-06-04</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0002">
<mixed-citation id="mgg3964-cit-0002" publication-type="journal">
<string-name>
<surname>Abramov</surname>, <given-names>D. D.</given-names>
</string-name>, <string-name>
<surname>Kadochnikova</surname>, <given-names>V. V.</given-names>
</string-name>, <string-name>
<surname>Yakimova</surname>, <given-names>E. G.</given-names>
</string-name>, <string-name>
<surname>Belousova</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Maerle</surname>, <given-names>A. V.</given-names>
</string-name>, <string-name>
<surname>Sergeev</surname>, <given-names>I. V.</given-names>
</string-name>, … <string-name>
<surname>Trofimov</surname>, <given-names>D. Y.</given-names>
</string-name> (<year>2015</year>). <article-title>High carrier frequency of CFTR gene mutations associated with cystic fibrosis, and PAH gene mutations associated with phenylketonuria in Russian population</article-title>. <source xml:lang="en"/>Bulletin of Russian State Medical University, <volume>4</volume>, <fpage>32</fpage>–<lpage>35</lpage>.</mixed-citation>
</ref>
<ref id="mgg3964-bib-0003">
<mixed-citation id="mgg3964-cit-0003" publication-type="journal">
<string-name>
<surname>Ala</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Walker</surname>, <given-names>A. P.</given-names>
</string-name>, <string-name>
<surname>Ashkan</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Dooley</surname>, <given-names>J. S.</given-names>
</string-name>, &amp; <string-name>
<surname>Schilsky</surname>, <given-names>M. L.</given-names>
</string-name> (<year>2007</year>). <article-title>Wilson’s disease</article-title>. <source xml:lang="en"/>The Lancer, <volume>369</volume>, <fpage>397</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-803678-5.00495-1</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0004">
<mixed-citation id="mgg3964-cit-0004" publication-type="journal">
<string-name>
<surname>Auton</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Abecasis</surname>, <given-names>G. R.</given-names>
</string-name>, <string-name>
<surname>Altshuler</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Durbin</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Bentley</surname>, <given-names>D. R.</given-names>
</string-name>, <string-name>
<surname>Chakravarti</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Schloss</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2015</year>). <article-title>A global reference for human genetic variation</article-title>. <source xml:lang="en"/>Nature, <volume>526</volume>(<issue>7571</issue>), <fpage>68</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
<pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0005">
<mixed-citation id="mgg3964-cit-0005" publication-type="journal">
<string-name>
<surname>Barbitoff</surname>, <given-names>Y. A.</given-names>
</string-name>, <string-name>
<surname>Bezdvornykh</surname>, <given-names>I. V.</given-names>
</string-name>, <string-name>
<surname>Polev</surname>, <given-names>D. E.</given-names>
</string-name>, <string-name>
<surname>Serebryakova</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Glotov</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Glotov</surname>, <given-names>O. S.</given-names>
</string-name>, &amp; <string-name>
<surname>Predeus</surname>, <given-names>A. V.</given-names>
</string-name> (<year>2018</year>). <article-title>Catching hidden variation: Systematic correction of reference minor allele annotation in clinical variant calling</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>20</volume>(<issue>3</issue>), <fpage>360</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.168</pub-id>
<pub-id pub-id-type="pmid">29155419</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0006">
<mixed-citation id="mgg3964-cit-0006" publication-type="journal">
<string-name>
<surname>Barbitoff</surname>, <given-names>Y. A.</given-names>
</string-name>, <string-name>
<surname>Polev</surname>, <given-names>D. E.</given-names>
</string-name>, <string-name>
<surname>Shcherbakova</surname>, <given-names>I. V.</given-names>
</string-name>, <string-name>
<surname>Glotov</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Serebryakova</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Glotov</surname>, <given-names>O. S.</given-names>
</string-name>, &amp; <string-name>
<surname>Predeus</surname>, <given-names>A. V.</given-names>
</string-name> (<year>2018</year>). <article-title>Systematic dissection of biases in whole‐exome and whole‐genome sequencing reveals major determinants of coding sequence coverage</article-title>. <source xml:lang="en"/>BioRxiv, <fpage>387639</fpage>, <pub-id pub-id-type="doi">10.1101/387639</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0007">
<mixed-citation id="mgg3964-cit-0007" publication-type="journal">
<string-name>
<surname>Barbitoff</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Serebryakova</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Nasykhova</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Predeus</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Polev</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Shuvalova</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Glotov</surname>, <given-names>A.</given-names>
</string-name> (<year>2018</year>). <article-title>Identification of novel candidate markers of type 2 diabetes and obesity in Russia by exome sequencing with a limited sample size</article-title>. <source xml:lang="en"/>Genes, <volume>9</volume>, <fpage>415</fpage>
<pub-id pub-id-type="doi">10.3390/genes9080415</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0008">
<mixed-citation id="mgg3964-cit-0008" publication-type="journal">
<string-name>
<surname>Baumann</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Giunta</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Krabichler</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Rüschendorf</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Zoppi</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Colombi</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Fauth</surname>, <given-names>C.</given-names>
</string-name> (<year>2012</year>). <article-title>Mutations in FKBP14 cause a variant of Ehlers‐Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>90</volume>(<issue>2</issue>), <fpage>201</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.12.004</pub-id>
<pub-id pub-id-type="pmid">22265013</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0009">
<mixed-citation id="mgg3964-cit-0009" publication-type="journal">
<string-name>
<surname>Biesecker</surname>, <given-names>L. G.</given-names>
</string-name>, &amp; <string-name>
<surname>Green</surname>, <given-names>R. C.</given-names>
</string-name> (<year>2014</year>). <article-title>Diagnostic clinical genome and exome sequencing</article-title>. <source xml:lang="en"/>New England Journal of Medicine, <volume>370</volume>(<issue>25</issue>), <fpage>2418</fpage>–<lpage>2425</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1312543</pub-id>
<pub-id pub-id-type="pmid">24941179</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0010">
<mixed-citation id="mgg3964-cit-0010" publication-type="journal">
<string-name>
<surname>Cingolani</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Platts</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>L. L.</given-names>
</string-name>, <string-name>
<surname>Coon</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Ruden</surname>, <given-names>D. M.</given-names>
</string-name> (<year>2012</year>). <article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso‐2; iso‐3</article-title>. <source xml:lang="en"/>Fly, <volume>6</volume>(<issue>2</issue>), <fpage>80</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.4161/fly.19695</pub-id>
<pub-id pub-id-type="pmid">22728672</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0011">
<mixed-citation id="mgg3964-cit-0011" publication-type="journal">
<string-name>
<surname>de Bie</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Muller</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Wijmenga</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Klomp</surname>, <given-names>L. W. J.</given-names>
</string-name> (<year>2007</year>). <article-title>Molecular pathogenesis of Wilson and Menkes disease: Correlation of mutations with molecular defects and disease phenotypes</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>44</volume>(<issue>11</issue>), <fpage>673</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.052746</pub-id>
<pub-id pub-id-type="pmid">17717039</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0012">
<mixed-citation id="mgg3964-cit-0012" publication-type="journal">
<string-name>
<surname>DePristo</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Banks</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Poplin</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Garimella</surname>, <given-names>K. V.</given-names>
</string-name>, <string-name>
<surname>Maguire</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Hartl</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Daly</surname>, <given-names>M. J.</given-names>
</string-name> (<year>2011</year>). <article-title>A framework for variation discovery and genotyping using next‐generation DNA sequencing data</article-title>. <source xml:lang="en"/>Nature Geneticsenetics, <volume>43</volume>(<issue>5</issue>), <fpage>491</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0013">
<mixed-citation id="mgg3964-cit-0013" publication-type="journal">
<string-name>
<surname>Fakhro</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Staudt</surname>, <given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Ramstetter</surname>, <given-names>M. D.</given-names>
</string-name>, <string-name>
<surname>Robay</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Malek</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Badii</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Rodriguez‐Flores</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2016</year>). <article-title>The Qatar genome: A population‐specific tool for precision medicine in the middle east</article-title>. <source xml:lang="en"/>Human Genome Variation, <volume>3</volume>(<issue>1</issue>), <fpage>16016</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2016.16</pub-id>
<pub-id pub-id-type="pmid">27408750</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0014">
<mixed-citation id="mgg3964-cit-0014" publication-type="journal">
<string-name>
<surname>Fu</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>O’Connor</surname>, <given-names>T. D.</given-names>
</string-name>, <string-name>
<surname>Jun</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Kang</surname>, <given-names>H. M.</given-names>
</string-name>, <string-name>
<surname>Abecasis</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Leal</surname>, <given-names>S. M.</given-names>
</string-name>, … <string-name>
<surname>Akey</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2013</year>). <article-title>Analysis of 6,515 exomes reveals the recent origin of most human protein‐coding variants</article-title>. <source xml:lang="en"/>Nature, <volume>493</volume>(<issue>7431</issue>), <fpage>216</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/nature11690</pub-id>
<pub-id pub-id-type="pmid">23201682</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0101">
<mixed-citation id="mgg3964-cit-0101" publication-type="journal">
<string-name>
<surname>Guo</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sheng</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Ye</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lehmann</surname>, <given-names>B.</given-names>
</string-name>, … <string-name>
<surname>Shyr</surname>, <given-names>Y.</given-names>
</string-name> (<year>2014</year>). <article-title>Multi-perspective quality control of Illumina exome sequencing data using QC3</article-title>. <source xml:lang="en"/>Genomics, <volume>103</volume>(<issue>5-6</issue>), <fpage>323</fpage>–<lpage>328</lpage>, <pub-id pub-id-type="doi">10.1016/j.ygeno.2014.03.006</pub-id>
<pub-id pub-id-type="pmid">24703969</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0015">
<mixed-citation id="mgg3964-cit-0015" publication-type="journal">
<string-name>
<surname>Karczewski</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Francioli</surname>, <given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Tiao</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Cummings</surname>, <given-names>B. B.</given-names>
</string-name>, <string-name>
<surname>Alföldi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Q.</given-names>
</string-name>, … <string-name>
<surname>MacArthur</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2019</year>). <article-title>Variation across 141,456 human exomes and genomes reveals the spectrum of loss‐of‐function intolerance across human protein‐coding genes</article-title>. <source xml:lang="en"/>BioRxiv, <fpage>531210</fpage>, <pub-id pub-id-type="doi">10.1101/531210</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0016">
<mixed-citation id="mgg3964-cit-0016" publication-type="journal">
<string-name>
<surname>Lazarin</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Haque</surname>, <given-names>I. S.</given-names>
</string-name>, <string-name>
<surname>Nazareth</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Iori</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Patterson</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Jacobson</surname>, <given-names>J. L.</given-names>
</string-name>, … <string-name>
<surname>Srinivasan</surname>, <given-names>B. S.</given-names>
</string-name> (<year>2013</year>). <article-title>An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: Results from an ethnically diverse clinical sample of 23,453 individuals</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>15</volume>(<issue>3</issue>), <fpage>178</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2012.114</pub-id>
<pub-id pub-id-type="pmid">22975760</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0017">
<mixed-citation id="mgg3964-cit-0017" publication-type="journal">
<string-name>
<surname>Lek</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Karczewski</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Samocha</surname>, <given-names>K. E.</given-names>
</string-name>, <string-name>
<surname>Banks</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Fennell</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>O'Donnell‐Luria</surname>, <given-names>A. H.</given-names>
</string-name>, … <string-name>
<surname>MacArthur</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2016</year>). <article-title>Analysis of protein‐coding genetic variation in 60,706 humans</article-title>. <source xml:lang="en"/>Nature, <volume>536</volume>(<issue>7616</issue>), <fpage>283</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1101/030338</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0018">
<mixed-citation id="mgg3964-cit-0018" publication-type="journal">
<string-name>
<surname>Li</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Durbin</surname>, <given-names>R.</given-names>
</string-name> (<year>2009</year>). <article-title>Fast and accurate short read alignment with Burrows‐Wheeler transform</article-title>. <source xml:lang="en"/>Bioinformatics (Oxford, England), <volume>25</volume>(<issue>14</issue>), <fpage>1754</fpage>–<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1101/gr.129684.111</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0019">
<mixed-citation id="mgg3964-cit-0019" publication-type="journal">
<string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Boerwinkle</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Jolla</surname>, <given-names>L.</given-names>
</string-name>, &amp; <string-name>
<surname>Genome</surname>, <given-names>H.</given-names>
</string-name> (<year>2016</year>). <article-title>dbNSFP v3. 0: A One‐Stop Database of Functional Predictions and Annotations for Human Non‐synonymous and Splice Site SNVs</article-title>. <source xml:lang="en"/>Human Mutation, <volume>37</volume>(<issue>3</issue>), <fpage>235</fpage>–<lpage>241</lpage>.<pub-id pub-id-type="pmid">26555599</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0020">
<mixed-citation id="mgg3964-cit-0020" publication-type="journal">
<string-name>
<surname>Mannucci</surname>, <given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Duga</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Peyvandi</surname>, <given-names>F.</given-names>
</string-name> (<year>2004</year>). <article-title>Recessively inherited coagulation disorders</article-title>. <source xml:lang="en"/>Blood, <volume>104</volume>(<issue>5</issue>), <fpage>1243</fpage>–<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2004-02-0595.Supported</pub-id>
<pub-id pub-id-type="pmid">15138162</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0021">
<mixed-citation id="mgg3964-cit-0021" publication-type="journal">
<string-name>
<surname>Ng</surname>, <given-names>S. B.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>, <given-names>E. H.</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>, <given-names>P. D.</given-names>
</string-name>, <string-name>
<surname>Flygare</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<surname>Bigham</surname>, <given-names>A. W.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Shendure</surname>, <given-names>J.</given-names>
</string-name> (<year>2009</year>). <article-title>Targeted capture and massively parallel sequencing of 12 human exomes</article-title>. <source xml:lang="en"/>Nature, <volume>461</volume>, <fpage>272</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1038/nature08250</pub-id>
<pub-id pub-id-type="pmid">19684571</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0022">
<mixed-citation id="mgg3964-cit-0022" publication-type="journal">
<string-name>
<surname>Nykamp</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Powers</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Herrera</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ho</surname>, <given-names>Y.‐Y.</given-names>
</string-name>, … <string-name>
<surname>Topper</surname>, <given-names>S.</given-names>
</string-name> (<year>2017</year>). <article-title>Sherloc: A comprehensive refinement of the ACMG–AMP variant classification criteria</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>19</volume>(<issue>10</issue>), <fpage>1105</fpage>–<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.37</pub-id>
<pub-id pub-id-type="pmid">28492532</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0023">
<mixed-citation id="mgg3964-cit-0023" publication-type="journal">
<string-name>
<surname>Oleksyk</surname>, <given-names>T. K.</given-names>
</string-name>, <string-name>
<surname>Brukhin</surname>, <given-names>V.</given-names>
</string-name>, &amp; <string-name>
<surname>O’Brien</surname>, <given-names>S. J.</given-names>
</string-name> (<year>2015</year>). <article-title>The Genome Russia project: Closing the largest remaining omission on the world Genome map</article-title>. <source xml:lang="en"/>GigaScience, <volume>4</volume>(<issue>1</issue>), <fpage>1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1186/s13742-015-0095-0</pub-id>
<pub-id pub-id-type="pmid">25838885</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0024">
<mixed-citation id="mgg3964-cit-0024" publication-type="journal">
<string-name>
<surname>Richards</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Bale</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bick</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gastier‐Foster</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Rehm</surname>, <given-names>H. L.</given-names>
</string-name> (<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>17</volume>(<issue>5</issue>), <fpage>405</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0025">
<mixed-citation id="mgg3964-cit-0025" publication-type="journal">
<string-name>
<surname>Rodriguez‐Flores</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Fakhro</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Hackett</surname>, <given-names>N. R.</given-names>
</string-name>, <string-name>
<surname>Salit</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Fuller</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Agosto‐Perez</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Crystal</surname>, <given-names>R. G.</given-names>
</string-name> (<year>2014</year>). <article-title>Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in qatar</article-title>. <source xml:lang="en"/>Human Mutation, <volume>35</volume>(<issue>1</issue>), <fpage>105</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22460</pub-id>
<pub-id pub-id-type="pmid">24123366</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0026">
<mixed-citation id="mgg3964-cit-0026" publication-type="journal">
<string-name>
<surname>Sheremet</surname>, <given-names>N. L.</given-names>
</string-name>, <string-name>
<surname>Zhorzholadze</surname>, <given-names>N. V.</given-names>
</string-name>, <string-name>
<surname>Ronzina</surname>, <given-names>I. A.</given-names>
</string-name>, <string-name>
<surname>Grushke</surname>, <given-names>I. G.</given-names>
</string-name>, <string-name>
<surname>Kurbatov</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Chukhrova</surname>, <given-names>A. L.</given-names>
</string-name>, … <string-name>
<surname>Strel’nikov</surname>, <given-names>V. V.</given-names>
</string-name> (<year>2017</year>). <article-title>Molecular genetic diagnosis of Stargardt disease</article-title>. <source xml:lang="en"/>Vestnik Oftalmologii, <volume>133</volume>(<issue>4</issue>), <fpage>4</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.17116/oftalma201713344-11</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0027">
<mixed-citation id="mgg3964-cit-0027" publication-type="journal">
<string-name>
<surname>Takeda</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tomita</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Matsunaga</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Tagami</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Shubahar</surname>, <given-names>S.</given-names>
</string-name> (<year>1990</year>). <article-title>Basis of tyrosinase‐negative oculocutaneous albinism</article-title>. <source xml:lang="en"/>The Journal of Biological Chemistry, <volume>265</volume>(<issue>29</issue>), <fpage>17792</fpage>–<lpage>17797</lpage>.<pub-id pub-id-type="pmid">2120217</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0028">
<mixed-citation id="mgg3964-cit-0028" publication-type="journal">
<string-name>
<surname>Tighe</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Dunican</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Bertorelle</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Beattie</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Graham</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Croke</surname>, <given-names>D. T.</given-names>
</string-name> (<year>2003</year>). <article-title>Genetic diversity within the R408W phenylketonuria mutation lineages in Europe</article-title>. <source xml:lang="en"/>Human Mutation, <volume>21</volume>(<issue>4</issue>), <fpage>387</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1002/humu.10195</pub-id>
<pub-id pub-id-type="pmid">12655548</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0029">
<mixed-citation id="mgg3964-cit-0029" publication-type="journal">
<string-name>
<surname>Van der Auwera</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Carneiro</surname>, <given-names>M. O.</given-names>
</string-name>, <string-name>
<surname>Hartl</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Poplin</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>del Angel</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Levy‐Moonshine</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>DePristo</surname>, <given-names>M. A.</given-names>
</string-name> (<year>2013</year>). <article-title>From FastQ data to high‐confidence variant calls: The genome analysis toolkit best practices pipeline</article-title>. <source xml:lang="en"/>Current Protocols in Bioinformatics, <volume>43</volume>, <fpage>11.10.1</fpage>–<lpage>11.10.33</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id>
<pub-id pub-id-type="pmid">25431634</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0030">
<mixed-citation id="mgg3964-cit-0030" publication-type="journal">
<string-name>
<surname>Walter</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Min</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Huang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Crooks</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Memari</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Zhang</surname>, <given-names>W.</given-names>
</string-name> (<year>2015</year>). <article-title>The UK10K project identifies rare variants in health and disease</article-title>. <source xml:lang="en"/>Nature, <volume>526</volume>(<issue>7571</issue>), <fpage>82</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1038/nature14962</pub-id>
<pub-id pub-id-type="pmid">26367797</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0031">
<mixed-citation id="mgg3964-cit-0031" publication-type="journal">
<string-name>
<surname>Wulff</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>Herrmann</surname>, <given-names>F. H.</given-names>
</string-name> (<year>2000</year>). <article-title>Twenty two novel mutations of the factor VII gene in factor VII deficiency</article-title>. <source xml:lang="en"/>Human Mutation, <volume>15</volume>(<issue>6</issue>), <fpage>489</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1004(200006)15:6&lt;489:AID-HUMU1&gt;3.0.CO;2-J</pub-id>
<pub-id pub-id-type="pmid">10862079</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0032">
<mixed-citation id="mgg3964-cit-0032" publication-type="journal">
<string-name>
<surname>Zhao</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Fan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Shang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>X.</given-names>
</string-name>, &amp; <string-name>
<surname>Chen</surname>, <given-names>Y.</given-names>
</string-name> (<year>2019</year>). <article-title>Pilot study of expanded carrier screening for 11 recessive diseases in China : Results from 10,476 ethnically diverse couples</article-title>. <source xml:lang="en"/>European Journal of Human Genetics, <volume>27</volume>(<issue>2</issue>), <fpage>254</fpage>–<lpage>262</lpage>, <pub-id pub-id-type="doi">10.1038/s41431-018-0253-9</pub-id>
<pub-id pub-id-type="pmid">30275481</pub-id></mixed-citation>
</ref>
<ref id="mgg3964-bib-0033">
<mixed-citation id="mgg3964-cit-0033" publication-type="journal">
<string-name>
<surname>Zhernakova</surname>, <given-names>D. V.</given-names>
</string-name>, <string-name>
<surname>Brukhin</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Malov</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Oleksyk</surname>, <given-names>T. K.</given-names>
</string-name>, <string-name>
<surname>Koepfli</surname>, <given-names>K. P.</given-names>
</string-name>, <string-name>
<surname>Zhuk</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>O'Brien</surname>, <given-names>S. J.</given-names>
</string-name>
<article-title>Genome‐wide sequence analyses of ethnic populations across Russia</article-title>. <source xml:lang="en"/>Genomics, <fpage>1</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2019.03.007</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0034">
<mixed-citation id="mgg3964-cit-0034" publication-type="journal">
<string-name>
<surname>Zhernakova</surname>, <given-names>D. V.</given-names>
</string-name>, <string-name>
<surname>Kliver</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Cherkasov</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Tamazian</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Rotkevich</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Krasheninnikova</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>O'Brien</surname>, <given-names>S. J.</given-names>
</string-name> (<year>2018</year>). <article-title>Analytical “bake‐off” of whole genome sequencing quality for the genome Russia project using a small cohort for autoimmune hepatitis</article-title>. <source xml:lang="en"/>PLoS ONE, <volume>13</volume>(<issue>7</issue>), <fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0200423</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3964-bib-0035">
<mixed-citation id="mgg3964-cit-0035" publication-type="journal">
<string-name>
<surname>Zol'nikova</surname>, <given-names>I. V.</given-names>
</string-name>, <string-name>
<surname>Ivanova</surname>, <given-names>M. E.</given-names>
</string-name>, <string-name>
<surname>Strel'nikov</surname>, <given-names>V. V.</given-names>
</string-name>, <string-name>
<surname>Levina</surname>, <given-names>D. V.</given-names>
</string-name>, <string-name>
<surname>Demenkova</surname>, <given-names>O. N.</given-names>
</string-name>, <string-name>
<surname>Tanas</surname>, <given-names>A. S.</given-names>
</string-name>, … <string-name>
<surname>Prikazyuk</surname>, <given-names>E. Y.</given-names>
</string-name> (<year>2016</year>). <article-title>The spectrum of mutations in the patients presenting with ABCA4‐associated Stargardt disease in a Russian population</article-title>. <source xml:lang="en"/>Russian Pediatric Ophtalmology, <volume>11</volume>(<issue>1</issue>), <fpage>14</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.18821/1993-1859-2016-11-1-14-22</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>